中文名:克唑替尼
英文名:Crizotinib
中文别名:克里唑替尼|3-[(1R)-1-(2,6-二氯-3-氟苯基)乙氧基]-5-[1-(4-哌啶)-1H-吡唑-4-基]-2-吡啶胺|克唑替尼|(R)-3-[1-(2,6-二氯-3-氟 - 苯基)-乙氧基]-5-(1-哌啶-4-基-1H-吡唑-4-基)-吡啶-2-基胺|克唑替尼|PF02341066|PF 2341066
英文别名:Crizotinib|877399-52-5|Xalkori|(R)-crizotinib|PF-02341066|PF-2341066|PF 2341066|(R)-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-amine|Crizotinib (PF-02341066)|crizotinibum|3-[(1R)-1-(2,6-Dichloro-3-fluoropheny
纯度:≥99%
货号:C137735
包装:1g、5g、25g
Cas号:877399-52-5
存储温度:2-8°C储存
产品介绍:
PF-2341066 shows inhibition of Met phosphorylation in mIMCD3 mouse of MDCK canine epithelial cells with an IC50 of 5 nM and 20 nM, respectively, as well as NCI-H69 and HOP92 cells, with an IC50 of 13 nM and 16 nM, respectively. PF-2341066 shows a near-equivalent IC50 of 24 nM against the nucleophosmin (NPM)-anaplastic lymphoma kinase (ALK) oncogenic fusion varient of the ALK RTK expressed by the KARPAS299 human anaplastic large-cell lymphoma (ALCL) cell line. PF-2341066 supresses human GTL-16 gastric carcinoma cell growth with an IC50 of 9.7 nM. PF-2341066 induces apoptosis in GTL-16 cells with an IC5050 of 30 nM.
A Met inhibitor effective against various cell lines
Crizotinib has been used:
· to investigate its effects on hepatocyte growth factor receptor (c-Met) expression, proliferation and apoptosis
· to block neurotrophic tyrosine kinase receptor type 1 (NTRK1) activity in epithelial cells
· to restore sensitivity to erlotinib
查看阿拉丁官网此产品相关对应页面:https://www.aladdin-e.com/zh_cn/C137735.html
关键字: 克里唑替尼;3-[(1R)-1-(2,6-二氯-3-氟苯基)乙氧基]-5-[1-(4-哌啶)-1H-吡唑-4-基]-2-吡啶胺;克唑替尼;(R)-3-[1-(2,6-二氯-3-氟 - 苯基)-乙氧基]-5-(1-哌啶-4-基-1H-吡唑-4-基)-吡啶-2-基胺
上海阿拉丁生化科技股份有限公司是A股上市公司((股票代码:688179),专注于科研试剂的研发、生产和销售,已陆续建立多个工厂和研发中心。作为领军企业,阿拉丁始终坚持质量第一,连续13年被评为“最受欢迎试剂品牌”。
阿拉丁目前常备库存试剂产品品种超过7万种,SKU总数超过46万,产品线涵盖了化学试剂、生化试剂、药靶配体、蛋白质和抗体等多个领域,是国内少数化学试剂到生物试剂全面发展的国产试剂品牌,产品同步发布在我们国内(www.aladdin-e.com)和海外(www.aladdinsci.com)电商平台。